$14,685.77 speaking Payment -- Allergan (AbbVie) to Dr. Heather Mitchell
Neurologist Receives Over $14,000 for Speaker Services from Allergan (AbbVie)
This page provides a detailed analysis of a $14,685.77 speaking payment from Allergan (AbbVie) to Dr. Heather Mitchell. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $14,685.77 |
| Payment Type | speaking |
| Payment Nature | Compensation for serving as faculty or as a speaker |
| Pharmaceutical Company | Allergan (AbbVie) |
| Physician | Dr. Heather Mitchell |
| NPI Number | 1356002744 |
| Physician Specialty | Neurology |
| Location | City, MD |
| Date of Payment | 2024-10-03 |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Allergan (AbbVie) made a $14.7K speaking payment to Heather Mitchell, a Neurology specialist in City, MD. The payment of $14,685.77 to Dr. Heather Mitchell from Allergan (AbbVie) on October 3, 2024, was for services as a speaker. This payment falls under the 'speaking' category, indicating compensation for educational or informational activities. The amount is substantial, suggesting a significant engagement or series of engagements as a faculty member or speaker.
Patient Guidance: What This Payment Means for You
This payment was for your role as a speaker or faculty member, which is a common way for healthcare professionals to share their expertise. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Payments for speaking engagements in Neurology can vary widely, but this amount suggests a significant role as an educator or presenter for Allergan (AbbVie).
Regulatory Context: Sunshine Act Requirements
Payments to physicians for speaking engagements are subject to disclosure under the Sunshine Act, requiring transparency in financial relationships between healthcare providers and industry.
Related Topics
This payment is related to the following healthcare transparency topics:
- speaker-fees
- pharmaceutical-payments
- neurology
- allergan
- abbvie
- physician-compensation
Understanding speaking Payments
Speaking and education payments compensate physicians for presenting at conferences, continuing medical education (CME) events, and promotional speaking engagements. These payments often cover honoraria, preparation time, and travel expenses. Speaking fees are among the highest-value payment categories and have attracted significant attention from researchers studying potential conflicts of interest.
Frequently Asked Questions About This Payment
What was this $14.7K payment for?
This was a speaking payment of $14.7K from Allergan (AbbVie) to Heather Mitchell, categorized as "Compensation for serving as faculty or as a speaker". The payment was reported under the Sunshine Act (CMS Open Payments).
Does Heather Mitchell accept pharmaceutical money?
Yes, Heather Mitchell received this $14.7K payment from Allergan (AbbVie). Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Heather Mitchell's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this speaking payment?
A speaking payment of $14.7K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Neurology?
To compare this payment against Neurology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Neurology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Heather Mitchell's relationship with Allergan (AbbVie)?
The payment was made by Allergan, now part of AbbVie, a major pharmaceutical company. This $14.7K speaking payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Neurology?
Dr. Mitchell's specialty is Neurology, aligning with potential therapeutic areas of Allergan/AbbVie.
What should patients do after learning about this payment?
This payment was for your role as a speaker or faculty member, which is a common way for healthcare professionals to share their expertise.
What else should I know about this speaking payment?
The payment date is recent, falling within the 2024 reporting period.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.